Key result
Review guides risk stratification to identify high-risk arrhythmic mitral valve prolapse in athletes.
Why the study?
Mitral valve prolapse encompasses a spectrum of conditions in athletes, with recent focus on malignant arrhythmic forms linked to sudden cardiac death requiring specific evaluation before competition clearance.
How should athletes with mitral valve prolapse be evaluated and managed to identify high-risk features of arrhythmic mitral valve prolapse?
How should athletes with mitral valve prolapse be evaluated and managed to identify high-risk features of arrhythmic mitral valve prolapse?
This review provides clinical guidance on managing athletes with mitral valve prolapse, emphasizing the differentiation of physiological remodeling from significant mitral regurgitation and the identification of high-risk arrhythmic features.
May inform athlete evaluation for arrhythmic mitral valve prolapse risk; leaves open prospective validation of stratification.
INTRODUCTION: Under the term degenerative mitral valve prolapse different pathophysiological and clinical entities coexist in a spectrum ranging from Barlow's disease to fibroelastic deficiency, and represent the most common cause of mitral regurgitation in the general population and in athletes. Carrying a mitral valve prolapse is usually considered a benign condition for athletes, but recently the scientific literature has focused on the malignant, thus rare, arrhythmic mitral valve prolapse and its dramatic association with sudden cardiac death, so that specific features should be considered a red flag and prompt additional exams before clear for competition. DISCUSSION: As the athlete's heart is morphologically accompanied by remodelling and dilatation of the cardiac chambers induced by exercise, it may be challenging to differentiate the degree of left ventricular and atrial dilation induced by significant mitral regurgitation from physiological remodelling, especially in endurance athletes. CONCLUSION: This how-to article provides clinical and useful data to manage athletes with mitral valve prolapse and to distinguish high-risk athletes carrying the features of arrhythmic mitral valve prolapse.
No takes yet. Share an insight, caveat, or question.
Cavarretta et al. (2020) conducted a review in Mitral valve prolapse in athletes. Management of mitral valve prolapse was evaluated. This review provides clinical guidance on managing athletes with mitral valve prolapse and distinguishing high-risk individuals with features of arrhythmic mitral valve prolapse.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: